Growth factors maintain intratumoral heterogeneity and drive therapeutic resistance in triple-negative breast cancer.

Cell Rep · 2026 · PMC12959317 · PMID 41477765

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Treatment with trametinib led to a highly significant decrease in heterogeneity compared to the control condition.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.